RMP promotes venous metastases of hepatocellular carcinoma through promoting IL-6 transcription

Oncogene

Volumn 34, Issue 12, 2015, Pages 1575-1583

  Zhang, J ^a,b   Pan, Y F ^a,b   Ding, Z W ^a,b   Yang, G Z ^a,b   Tan, Y X ^a,b   Yang, C ^a,b   Jiang, T Y ^a,b   Liu, L J ^a,b   Zhang, B ^a,b   Han, T ^a,b   Cao, D ^a,b   Yang, T ^b   Yang, N ^b   Wu, M C ^b   Dong, L W ^a,b   Wang, H Y ^a,b,c  

^a National Scientific Centre for Liver Cancer   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; REPRESSOR PROTEIN; SIGNAL PEPTIDE; URI1 PROTEIN, HUMAN; URI1 PROTEIN, MOUSE;

ANIMAL; BAGG ALBINO MOUSE; CANCER STEM CELL; CANCER TRANSPLANTATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; PORTAL VEIN; TUMOR CELL LINE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PORTAL VEIN; REPRESSOR PROTEINS;

EID: 84897351102     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.84     Document Type: Article

References (32)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 2006; 243: 229-235.
3. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16.
4. Weinstein IB. Cancer. Addiction to oncogenes-the Achilles heal of cancer. Science 2002; 297: 63-64.
5. He G, Karin M. NF-kappaB and STAT3-key players in liver inflammation and cancer. Cell Res 2011; 21: 159-168.
6. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 121-124.
7. Johnson C, Han Y, Hughart N, McCarra J, Alpini G, Meng F. Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer 2012; 1: 58-70.
8. Yamashita T, Honda M, Nio K, Nakamoto Y, Takamura H, Tani T et al. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation. Cancer Res 2010; 70: 4687-4697.
9. Lee TK, Castilho A, Cheung VC, Tang KH, Ma S, Ng IO. CD24(+) liver tumorinitiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 2011; 9: 50-63.
10. Dorjsuren D, Lin Y, Wei W, Yamashita T, Nomura T, Hayashi N et al. RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol Cell Biol 1998; 18: 7546-7555.
11. Parusel CT, Kritikou EA, Hengartner MO, Krek W, Gotta M. URI-1 is required for DNA stability in C. elegans. Development 2006; 133: 621-629.
12. Theurillat JP, Metzler SC, Henzi N, Djouder N, Helbling M, Zimmermann AK et al. URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell 2011; 19: 317-332.
13. Wei W, Dorjsuren D, Lin Y, Qin W, Nomura T, Hayashi N et al. Direct interaction between the subunit RAP30 of transcription factor IIF (TFIIF) and RNA polymerase subunit 5, which contributes to the association between TFIIF and RNA polymerase II. J Biol Chem 2001; 276: 12266-12273.
14. Yang S, Wang H, Guo Y, Chen S, Zhang MY, Shen J et al. RMP plays distinct roles in the proliferation of hepatocellular carcinoma cells and normal hepatic cells. Int J Biol Sci 2013; 9: 637-648.
15. Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF, Tang L et al. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. BMC Cancer 2011; 11: 271.
16. Baccelli I, Trumpp A. The evolving concept of cancer and metastasis stem cells. J Cell Biol 2012; 198: 281-293.
17. Ji J, Wang XW. Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol 2012; 39: 461-472.
18. Spooren A, Kooijman R, Lintermans B, Van Craenenbroeck K, Vermeulen L, Haegeman G et al. Cooperation of NFkappaB and CREB to induce synergistic IL-6 expression in astrocytes. Cell Signal 2010; 22: 871-881.
19. Yoon S, Woo SU, Kang JH, Kim K, Kwon MH, Park S et al. STAT3 transcriptional factor activated by reactive oxygen species induces IL6 in starvation-induced autophagy of cancer cells. Autophagy 2010; 6: 1125-1138.
20. Zhang Y, Bharadwaj U, Logsdon CD, Chen C, Yao Q, Li M. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res 2010; 16: 1423-1430.
21. Acker J, Cheynel I, Khazak V, Kedinger C, Vigneron M. Interactions between the human RNA polymerase II subunits. J Biol Chem 1997; 272: 16815-16821.
22. Wang T, Hu HS, Feng YX, Shi J, Li N, Guo WX et al. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br J Cancer 2010; 102: 1618-1626.
23. Iliopoulos D, Hirsch HA, Wang G, Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci USA 2011; 108: 1397-1402.
24. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
25. Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009; 28: 2940-2947.
26. Xiang WQ, Feng WF, Ke W, Sun Z, Chen Z, Liu W. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway. J Hepatol 2011; 54: 26-33.
27. He G, Dhar D, Nakagawa H, Font-Burgada J, Ogata H, Jiang Y et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 2013; 155: 384-396.
28. Jang JW, Oh BS, Kwon JH, You CR, Chung KW, Kay CS et al. Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma. Cytokine 2012; 60: 686-693.
29. Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T et al. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer 2009; 125: 2264-2269.
30. Wong VW, Yu J, Cheng AS, Wong GL, Chan HY, Chu ES et al. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer 2009; 124: 2766-2770.
31. Dong LW, Hou YJ, Tan YX, Tang L, Pan YF, Wang M et al. Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma. Autophagy 2011; 7: 1222-1229.
32. Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY et al. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res 2005; 65: 8861-8868.